Heart disease kills more human beings than anything else on earth each year, accounting for 18 million deaths – about 31% of all global deaths. Solving heart disease has been one of humanity’s greatest challenges since the beginning of medicine but sadly, scientists have not been able to figure it out.
The impact of deaths from heart disease go beyond the millions of people who lose their own lives, and extend to the families of all of those victims. This creates a ripple effect that reaches tens of millions of people, and affects their lives in ways spanning from their families’ income to caring for children.
While many scientists work on curing cardiovascular diseases, others have spent the last 50 years improving the process of transplanting human hearts. First successfully performed in 1967, these human-to-human medical procedures have extended the lives of fortunate recipients. While this has been one of humanity’s greatest medical achievements, it cannot increase the amount of hearts available.
Increasing the supply of human hearts available for transplant would have the potential to save millions of lives, and that’s why BIOLIFE4D is laser-focused on doing just that. We aim to 3D bioprint transplantable human hears from patients’ own cells, which would not only make more available but also make it more likely that recipients’ bodies will accept the organs and that they will be able to function properly.
Humanity needs this technology, as well as the medical community. There are about 4,000 people on the U.S. waiting list for heart transplants, and a staggering 200,000 more who can’t join the waiting list because of the short supply. Over a heart recipient’s lifetime, the transplant will cost about $1.4 million, so this technology has a $280 billion potential – and that’s just in the United States.
To have a chance at realizing that potential, we need investment from people who believe in the global impact that this technology can have and the millions of lives that it can save. It requires thoughtful investment but the time to consider it is almost up, as our Regulation A+ offering closes in just two weeks. Will you play a part in what can be one of the greatest scientific achievements in world history?